Ilexgenin BCAS# 109008-39-1 |
2D Structure
Quality Control & MSDS
Package In Stock
Number of papers citing our products
Cas No. | 109008-39-1 | SDF | Download SDF |
PubChem ID | N/A | Appearance | Powder |
Formula | C30H48O4 | M.Wt | 472.71 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Ilexgenin B Dilution Calculator
Ilexgenin B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1155 mL | 10.5773 mL | 21.1546 mL | 42.3092 mL | 52.8865 mL |
5 mM | 0.4231 mL | 2.1155 mL | 4.2309 mL | 8.4618 mL | 10.5773 mL |
10 mM | 0.2115 mL | 1.0577 mL | 2.1155 mL | 4.2309 mL | 5.2887 mL |
50 mM | 0.0423 mL | 0.2115 mL | 0.4231 mL | 0.8462 mL | 1.0577 mL |
100 mM | 0.0212 mL | 0.1058 mL | 0.2115 mL | 0.4231 mL | 0.5289 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Quercitin-3′-O- glucofuranoside
Catalog No.:BCX0875
CAS No.:21637-25-2
- Demethoxydeacetoxypseudolaric acid B
Catalog No.:BCX0874
CAS No.:500736-17-4
- Breviscapine
Catalog No.:BCX0873
CAS No.:116122-36-2
- Celosin K
Catalog No.:BCX0872
CAS No.:1950579-53-9
- N-acetyldopamine dimmers A
Catalog No.:BCX0871
CAS No.:1519015-73-6
- Lugrandoside
Catalog No.:BCX0870
CAS No.:117457-37-1
- Acetyl Dopamine DimerIII
Catalog No.:BCX0869
CAS No.:916888-49-8
- α-Curcumene
Catalog No.:BCX0868
CAS No.:644-30-4
- Deacetylkadsurin
Catalog No.:BCX0867
CAS No.:51670-42-9
- Acetyl Dopamine DimerIV
Catalog No.:BCX0866
CAS No.:1632326-65-8
- Crocin E
Catalog No.:BCX0865
CAS No.:58050-17-2
- Polyporusterone C
Catalog No.:BCX0864
CAS No.:141360-90-9
- Cyanidin-3-Rutinosidechloride Cyanidin-3-Rutinoside
Catalog No.:BCX0877
CAS No.:28338-59-2
- Cyanidin3-O-2G-glucosylrutinoside
Catalog No.:BCX0878
CAS No.:755695-57-9
- Delphinidin-3-O-arabinoside
Catalog No.:BCX0879
CAS No.:28500-01-8
- Delphinidin-3-Rutinoside Delphinidin-3-Rutinosidechloride
Catalog No.:BCX0880
CAS No.:58285-26-0
- GalantamineHydrobromide
Catalog No.:BCX0881
CAS No.:69353-21-5
- (+)-Medicarpin
Catalog No.:BCX0882
CAS No.:33983-40-3
- Benzoylalbiflorin
Catalog No.:BCX0883
CAS No.:184103-78-4
- Allosecurinin
Catalog No.:BCX0884
CAS No.:884-68-4
- Lucenin-1 Luteolin-6-C-β-D-xylopyranoside-8-C-β-D-glucopyranosyl
Catalog No.:BCX0885
CAS No.:35927-39-0
- Lucenin-3 Luteolin-6-C-β-D-glucopyranosyl-8-C-β-D-xylopyranoside
Catalog No.:BCX0886
CAS No.:12656-83-6
- IsovitexinApigenin6-C-glucoside
Catalog No.:BCX0887
CAS No.:29702-25-8
- Delphinidin3-O-(6''-coumaroylglucoside)
Catalog No.:BCX0888
CAS No.:136031-08-8
Antiplatelet aggregation triterpene saponins from the barks of Ilex rotunda.[Pubmed:25447155]
Fitoterapia. 2015 Mar;101:19-26.
Four new triterpene saponins, rotundinosides A-D (1-4) and seven known triterpene saponins (5-11) were isolated from a methanol extract of the barks of Ilex rotunda Thunb. The new saponins were characterized as 3-O-beta-d-glucopyranosy1-(1-->2)-beta-d-xylopyranosyl siaresinolic acid 28-O-beta-d-glucopyranoside (1), 3-O-[beta-d-glucopyranosy1-(1-->2)-beta-d-xylopyranosyl]-3beta,19alpha-dihydroxyurs-12-en-28-oic-O-beta-d-glucopranosy1ester (2), 3-O-[alpha-l-rhamnopyranosyl-(1-->2)-beta-d-glucopyranosy1-(1-->2)-alpha-l-arabinopyranosyl]-3beta,19alpha-dihydroxyurs-12-en-28-oic-O-beta-d-glucopyranosy1 ester (3), and 3-O-alpha-l-rhamanopyranosyl-(1-->2)-beta-d-glucopyranosy1-(1-->2)-alpha-l-arabinopyranosyl Ilexgenin B 28-O-beta-d-glucopyranosy1 ester (4), respectively. Their structures were established by extensive spectroscopic analysis, including HSQC, HMBC, (1)H-(1)H COSY, NOESY and acid hydrolysis, and also by the comparison of their spectroscopic data with those of related compounds. The known compounds 5-11 were all obtained from this species for the first time. The biological activity of compounds 1-11 against ADP induced platelet aggregation in rabbit plasma was determined. Among the tested compounds 1, 3, 5 and 10 exhibited strong inhibition of platelet aggregation in vitro, with IC50 values of 11.4+/-2.2, 10.4+/-1.3, 13.2+/-2.4, and 15.1+/-3.4muM, respectively.
Triterpenoid saponins from Ilex mamillata C.Y. Wu ex C.J. Tseng.[Pubmed:22124275]
Nat Prod Res. 2012 Nov;26(21):1991-5.
Two new triterpenoid saponins, ilemaminosides A and B (1 and 2) along with six known saponins (3-8) were isolated from 70% ethanolic extract of the leaves of Ilex mamillata C.Y. Wu ex C.J. Tseng. The new saponins were characterised as 3-O-alpha-L-arabinopyranosyl-Ilexgenin B (1) and 3-O-beta-D-glucopyranosyl-(1 --> 3)-alpha-L-arabinopyranosyl-Ilexgenin B (2). The structures of compounds 1 and 2 were elucidated on the basis of the chemical and spectroscopic methods, and the structures of known compounds were identified by comparison of their spectroscopic data with those reported in the literature. The compounds showed inhibitory activities in anti-inflammatory assay in vitro with IC(50) values in the range 25.37-38.33 microg mL(-1).
Two new triterpenoid saponins from the root of Ilex pubescens.[Pubmed:18058383]
J Asian Nat Prod Res. 2008 Jan-Feb;10(1-2):71-5.
Two new triterpenoid saponins, named ilexsaponins B(4) (1) and C (2), have been isolated from the roots of Ilex pubescens. Their structures have been established as Ilexgenin B 3-O-alpha-L-arabinopyranosyl-(2-->1)-beta-D-glucopyranosyl-(2-->1)-beta-D-xylopyranoside (1) and 3-O-beta-D-xylopyranosyl spathodic acid 28-beta-D-glucopyranosyl ester (2) by means of spectral and chemical methods.
Triterpenoid saponins from Ilex latifolia.[Pubmed:9887534]
Phytochemistry. 1998 Dec;49(8):2483-6.
Three new triterpenoid saponins, latifolosides F, G, H were isolated from the leaves of Ilex latifolia. Their structures were elucidated on the basis of chemical and spectral evidence. Latifoloside F was determined to be 3-O-[alpha-L-rhamnopyranosyl(1-2)]-[beta-D-glucopyranosyl(1-3)-]- alpha-L-arabinopyranosyl Ilexgenin B 28-O-[alpha-L-rhamnopyranosyl(1-2)]-beta-D-glucopyranoside. Latifoloside G was 3-O-[alpha-L-rhamnopyranosyl(1-2)]-[beta-D-glucopyranosyl(1-3)-]- alpha-L-arabinopyranosyl pomolic acid 28-O-[alpha-L-rhamnopyranosyl(1-2)]-beta-D-glucopyranoside. Latifolioside H(3) was 3-O-[alpha-L-rhamnopyranosyl(1-2)]-[beta-D-glucopyranosyl(1-3)-]- alpha-L-arabinopyranosyl siaresinolic acid 28-O-[alpha-L-rhamnopyranosyl(1-2)]-beta-D-glucopyranoside.